Literature DB >> 6706749

Pulmonary vasoconstrictor response to acute decrease in blood P50.

B P Teisseire, C D Soulard.   

Abstract

The O2 sensor that triggers hypoxic pulmonary vasoconstriction may be sensitive not only to alveolar hypoxia but also to hypoxia in mixed venous blood. A specific test of the blood contribution would be to lower mixed venous PO2 (PvO2), which can be accomplished by increasing hemoglobin-O2 affinity. When we exchanged transfused rats with cyanate-treated erythrocytes [PO2 at 50% hemoglobin saturation (P50) = 21 Torr] or with Créteil erythrocytes (P50 = 13.1 Torr), we lowered PvO2 from 39 +/- 5 to 25 +/- 4 and to 14 +/- 4 Torr, respectively, without altering arterial blood gases or hemoglobin concentration. Right ventricular systolic pressure increased from 32 +/- 2 to 36 +/- 3 Torr with cyanate erythrocytes and to 44 +/- 5 Torr with Créteil erythrocytes. Cardiac output was unchanged. Control exchange transfusions with normal rat or 2,3-diphosphoglycerate-enriched human erythrocytes had no effect on PvO2 or right ventricular pressure. Alveolar hypoxia plus high O2 affinity blood caused a greater increase in right ventricular systolic pressure than either stimulus alone. We concluded that PvO2 is an important determinant of pulmonary vascular tone in the rat.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6706749     DOI: 10.1152/jappl.1984.56.2.370

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  3 in total

Review 1.  Hypoxia and the pulmonary circulation.

Authors:  I S Anand
Journal:  Thorax       Date:  1994       Impact factor: 9.139

2.  Exploration of the pulmonary circulation. Festschrift to Professor Donald Heath.

Authors: 
Journal:  Thorax       Date:  1994       Impact factor: 9.139

3.  Time-course of the polycythemic response in normoxic and hypoxic mice with high blood oxygen affinity induced by cyanate administration.

Authors:  M Rivera-Ch; F León-Velarde; L Huicho; C Monge-C
Journal:  J Comp Physiol B       Date:  1995       Impact factor: 2.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.